These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25015681)

  • 41. Predictive impacts of chronic kidney disease and cardiac sympathetic nervous activity on lethal arrhythmic events in chronic heart failure.
    Amami K; Yamada S; Yoshihisa A; Kaneshiro T; Hijioka N; Nodera M; Nehashi T; Takeishi Y
    Ann Noninvasive Electrocardiol; 2022 Jan; 27(1):e12900. PubMed ID: 34676627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relation between cardiac 123I-mIBG scintigraphy and functional response 1 year after CRT implantation.
    Verschure DO; Poel E; De Vincentis G; Frantellizzi V; Nakajima K; Gheysens O; de Groot JR; Verberne HJ
    Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):49-57. PubMed ID: 32259839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypertrophic cardiomyopathy: the importance of arrhythmic events in patients at risk for sudden cardiac death.
    Medeiros Pde T; Martinelli Filho M; Arteaga E; Costa R; Siqueira S; Mady C; Piegas LS; Ramires JA
    Arq Bras Cardiol; 2006 Nov; 87(5):649-57. PubMed ID: 17221043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy.
    Briongos-Figuero S; Estévez A; Pérez ML; Martínez-Ferrer JB; García E; Viñolas X; Arenal Á; Alzueta J; Muñoz-Aguilera R
    ESC Heart Fail; 2020 Feb; 7(1):279-283. PubMed ID: 31823514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD).
    Vehmeijer JT; Koyak Z; Leerink JM; Zwinderman AH; Harris L; Peinado R; Oechslin EN; Robbers-Visser D; Groenink M; Boekholdt SM; de Winter RJ; Oliver JM; Bouma BJ; Budts W; Van Gelder IC; Mulder BJM; de Groot JR
    Heart Rhythm; 2021 May; 18(5):785-792. PubMed ID: 33465514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcome of Patients with Advanced Heart Failure Who Receive Device-Based Therapy for Primary Prevention of Sudden Cardiac Death: Insights from the Israeli ICD Registry.
    Suleiman M; Goldenberg I; Samniah N; Rosso R; Marai I; Pekar A; Khalameizer V; Militianu A; Glikson M
    Pacing Clin Electrophysiol; 2015 Jun; 38(6):738-45. PubMed ID: 25754272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention.
    Kreuz J; Horlbeck F; Schrickel J; Linhart M; Fimmers R; Mellert F; Nickenig G; Schwab JO
    Clin Cardiol; 2012 Sep; 35(9):575-9. PubMed ID: 22707222
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials.
    Jacobson AF; Lombard J; Banerjee G; Camici PG
    J Nucl Cardiol; 2009; 16(1):113-21. PubMed ID: 19152136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: still a place in prognostication? Data from the GISSI-HF trial.
    La Rovere MT; Pinna GD; Maestri R; Barlera S; Bernardinangeli M; Veniani M; Nicolosi GL; Marchioli R; Tavazzi L;
    Eur J Heart Fail; 2012 Dec; 14(12):1410-9. PubMed ID: 22851700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prognostic value of
    Pontico M; Brunotti G; Conte M; Corica F; Cosma L; De Angelis C; De Feo MS; Lazri J; Matto A; Montebello M; Di Rocco A; Frantellizzi V; Farcomeni A; De Vincentis G
    J Nucl Cardiol; 2022 Aug; 29(4):1799-1809. PubMed ID: 33442819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
    Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
    Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of
    Travin MI; Henzlova MJ; van Eck-Smit BLF; Jain D; Carrió I; Folks RD; Garcia EV; Jacobson AF; Verberne HJ
    J Nucl Cardiol; 2017 Apr; 24(2):377-391. PubMed ID: 26791866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive value of cardiac autonomic indexes and MIBG washout in ICD recipients with mild to moderate heart failure.
    Koutelou M; Katsikis A; Flevari P; Theodorakis G; Livanis E; Georgiadis M; Voudris V; Kremastinos D
    Ann Nucl Med; 2009 Sep; 23(7):677-84. PubMed ID: 19662346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.
    Fudim M; Ali-Ahmed F; Parzynski CS; Ambrosy AP; Friedman DJ; Pokorney SD; Curtis JP; Fonarow GC; Masoudi FA; Hernandez AF; Al-Khatib SM
    JAMA Cardiol; 2020 Jun; 5(6):643-651. PubMed ID: 32211811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Creation of mortality risk charts using 123I meta-iodobenzylguanidine heart-to-mediastinum ratio in patients with heart failure: 2- and 5-year risk models.
    Nakajima K; Nakata T; Matsuo S; Jacobson AF
    Eur Heart J Cardiovasc Imaging; 2016 Oct; 17(10):1138-45. PubMed ID: 26705487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improving sudden cardiac death risk stratification by evaluating electrocardiographic measures of global electrical heterogeneity and clinical outcomes among patients with implantable cardioverter-defibrillators: rationale and design for a retrospective, multicenter, cohort study.
    Waks JW; Hamilton C; Das S; Ehdaie A; Minnier J; Narayan S; Niebauer M; Raitt M; Tompkins C; Varma N; Chugh S; Tereshchenko LG
    J Interv Card Electrophysiol; 2018 Jun; 52(1):77-89. PubMed ID: 29541969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sympathetic Dysautonomia in Heart Failure by 123I-MIBG: comparison between Chagasic, non-Chagasic and heart transplant patients.
    Marino VSP; Dumont SM; Mota LDG; Braga DS; Freitas SS; Moreira MDCV
    Arq Bras Cardiol; 2018 Aug; 111(2):182-190. PubMed ID: 30088556
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. An analysis using 123I-meta-iodobenzylguanidine scintigraphy.
    Wichter T; Hindricks G; Lerch H; Bartenstein P; Borggrefe M; Schober O; Breithardt G
    Circulation; 1994 Feb; 89(2):667-83. PubMed ID: 8313555
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic effect and modulation of cardiac sympathetic function in heart failure patients treated with cardiac resynchronization therapy.
    Moreira RI; Abreu A; Portugal G; Oliveira L; Oliveira M; Rodrigues I; Cruz MC; Cunha PS; Santos V; Clara HS; Carmo MM; Ferreira RC
    J Nucl Cardiol; 2020 Feb; 27(1):283-290. PubMed ID: 29992524
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Entropy of cardiac repolarization predicts ventricular arrhythmias and mortality in patients receiving an implantable cardioverter-defibrillator for primary prevention of sudden death.
    DeMazumder D; Limpitikul WB; Dorante M; Dey S; Mukhopadhyay B; Zhang Y; Moorman JR; Cheng A; Berger RD; Guallar E; Jones SR; Tomaselli GF
    Europace; 2016 Dec; 18(12):1818-1828. PubMed ID: 27044982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.